Serelis et al. studied the effects of anti-TNF-α treatment in 19 women with rheumatoid arthritis, showing no significant impact on body composition; however, there was an increase in adiponectin levels that can affect the systemic inflammation [11]. Here, ADIPOQ is linked to rheumatoid arthritis.